• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用简化的参考组织模型 2 无创定量 [F]SynVesT-1 结合。

Noninvasive quantification of [F]SynVesT-1 binding using simplified reference tissue model 2.

机构信息

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520- 8048, USA.

Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.

出版信息

Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):113-121. doi: 10.1007/s00259-024-06885-6. Epub 2024 Aug 19.

DOI:10.1007/s00259-024-06885-6
PMID:39155309
Abstract

PURPOSE

[F]SynVesT-1, a positron emission tomography (PET) radiotracer for the synaptic vesicle glycoprotein 2A (SV2A), demonstrates kinetics similar to [C]UCB-J, with high brain uptake, fast kinetics fitting well with the one-tissue compartment (1TC) model, and excellent test-retest reproducibility. Challenges arise due to the similarity between k and [Formula: see text] (efflux rate of the reference region), when applying the simplified reference tissue model (SRTM) and related methods in [C]UCB-J studies to accurately estimate [Formula: see text]. This study evaluated the suitability of these methods to estimate [F]SynVesT-1 binding using centrum semiovale (CS) or cerebellum (CER) as reference regions.

METHOD

Seven healthy participants underwent 120-min PET scans on the HRRT scanner with [F]SynVesT-1. Six participants underwent test and retest scans. Arterial blood sampling and metabolite analysis provided input functions for the 1TC model, serving as the gold standard for kinetic parameters values. SRTM, coupled SRTM (SRTMC) and SRTM2 estimated were applied to estimate [Formula: see text](ref: CS) and DVR(ref: CER) values. For SRTM2, the population average of [Formula: see text] was determined from the 1TC model applied to the reference region. Test-retest variability and minimum scan time were also calculated.

RESULTS

The 1TC k (1/min) values for CS and CER were 0.031 ± 0.004 and 0.021 ± 0.002, respectively. Although SRTMC [Formula: see text] was much higher than 1TC [Formula: see text], SRTMC underestimated BP(ref: CS) and DVR by an average of 3% and 1% across regions, respectively, due to similar bias in k and [Formula: see text] estimation. SRTM underestimated BP(ref: CS) by an average of 3%, but with the CER as reference region, SRTM estimation was unstable and DVR underestimation varied by region (mean 10%). Using population average [Formula: see text] values, SRTM2 BP and DVR showed the best agreement with 1TC estimates.

CONCLUSION

Our findings support the use of population [Formula: see text] value in SRTM2 with [F]SynVesT-1 for the estimation of [Formula: see text] or DVR, regardless of the choice of reference region.

摘要

目的

[F]SynVesT-1 是一种正电子发射断层扫描(PET)示踪剂,用于突触囊泡糖蛋白 2A(SV2A),其动力学与 [C]UCB-J 相似,具有高脑摄取率,快速动力学与单组织室(1TC)模型拟合良好,且具有出色的复测重现性。当在 [C]UCB-J 研究中应用简化参考组织模型(SRTM)和相关方法来准确估计 [Formula: see text] 时,由于 k 和 [Formula: see text](参考区域流出率)之间的相似性,会出现一些挑战。本研究评估了使用半卵圆中心(CS)或小脑(CER)作为参考区域,这些方法是否适合估计 [F]SynVesT-1 结合。

方法

七名健康参与者在 HRRT 扫描仪上进行了 120 分钟的 [F]SynVesT-1 PET 扫描。六名参与者接受了测试和复测扫描。动脉采血和代谢物分析为 1TC 模型提供了输入函数,作为动力学参数值的金标准。应用 SRTM、耦合 SRTM(SRTMC)和 SRTM2 估计来估计 [Formula: see text](参考:CS)和 DVR(参考:CER)值。对于 SRTM2,通过将 1TC 模型应用于参考区域来确定参考区域中 [Formula: see text] 的群体平均值。还计算了复测变异性和最小扫描时间。

结果

CS 和 CER 的 1TC k(1/min)值分别为 0.031±0.004 和 0.021±0.002。尽管 SRTMC [Formula: see text] 远高于 1TC [Formula: see text],但由于 k 和 [Formula: see text] 估计的相似偏差,SRTMC 平均低估了 BP(参考:CS)和 DVR 分别为 3%和 1%。SRTM 平均低估了 BP(参考:CS)的 3%,但当 CER 作为参考区域时,SRTM 估计不稳定,且 DVR 低估因区域而异(平均为 10%)。使用群体平均 [Formula: see text] 值,SRTM2 的 BP 和 DVR 与 1TC 估计值具有最佳一致性。

结论

我们的研究结果支持在 [F]SynVesT-1 中使用群体 [Formula: see text] 值和 SRTM2 来估计 [Formula: see text] 或 DVR,无论选择哪种参考区域。

相似文献

1
Noninvasive quantification of [F]SynVesT-1 binding using simplified reference tissue model 2.使用简化的参考组织模型 2 无创定量 [F]SynVesT-1 结合。
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):113-121. doi: 10.1007/s00259-024-06885-6. Epub 2024 Aug 19.
2
First-in-Human Evaluation of F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.人源化 F-SynVesT-1 的首次临床评估,一种用于突触囊泡糖蛋白 2A 的 PET 成像放射性配体。
J Nucl Med. 2021 Apr;62(4):561-567. doi: 10.2967/jnumed.120.249144. Epub 2020 Aug 28.
3
Assessment of test-retest reproducibility of [F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A.评估新型正电子发射断层扫描显像剂[F]SynVesT-1 检测突触小泡糖蛋白 2A 重测信度的研究。
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1327-1338. doi: 10.1007/s00259-020-05149-3. Epub 2021 Jan 8.
4
Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [F]SynVesT-1 PET in Parkinson's Disease.帕金森病中 [F]SynVesT-1 PET 参考区定量和减少扫描时间的初步评估。
Mol Imaging. 2023 Aug 11;2023:1855985. doi: 10.1155/2023/1855985. eCollection 2023.
5
First-in-Human Study of F-SynVesT-2: An SV2A PET Imaging Probe with Fast Brain Kinetics and High Specific Binding.F-SynVesT-2的首次人体研究:一种具有快速脑动力学和高特异性结合的SV2A正电子发射断层显像(PET)成像探针
J Nucl Med. 2024 Feb 15;65(3):462-9. doi: 10.2967/jnumed.123.266470.
6
A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [F]SDM-16.一种用于成像突触小泡蛋白 2A 的代谢稳定的 PET 示踪剂:[F]SDM-16 的合成与临床前特征。
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1482-1496. doi: 10.1007/s00259-021-05597-5. Epub 2021 Nov 11.
7
Quantification of SV2A Binding in Rodent Brain Using [F]SynVesT-1 and PET Imaging.利用[F]SynVesT-1 和 PET 成像技术对啮齿动物大脑中 SV2A 结合的定量分析。
Mol Imaging Biol. 2021 Jun;23(3):372-381. doi: 10.1007/s11307-020-01567-9. Epub 2020 Nov 30.
8
Kinetics and 28-day test-retest repeatability and reproducibility of [C]UCB-J PET brain imaging.[C]UCB-J 正电子发射断层扫描脑显像的动力学及 28 天测试-重测重复性和可再现性。
J Cereb Blood Flow Metab. 2021 Jun;41(6):1338-1350. doi: 10.1177/0271678X20964248. Epub 2020 Oct 8.
9
Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.18F-JNJ-42259152 的定量分析:一种新型磷酸二酯酶 10A PET 示踪剂:人体大脑中的动力学建模和重复测试研究。
J Nucl Med. 2013 Aug;54(8):1285-93. doi: 10.2967/jnumed.112.118679. Epub 2013 Jul 10.
10
First-in-Human Assessment of C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer.首例人体评估 C-LSN3172176,一种 M1 毒蕈碱型乙酰胆碱受体 PET 放射性配体。
J Nucl Med. 2021 Apr;62(4):553-560. doi: 10.2967/jnumed.120.246967. Epub 2020 Aug 28.

引用本文的文献

1
Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer's disease.在阿尔茨海默病中,突触丢失模式受脑连接组的限制,并由磷酸化tau蛋白调节。
Nat Commun. 2025 Jul 10;16(1):6356. doi: 10.1038/s41467-025-61497-4.
2
Network-based Molecular Constraints on Synaptic Density Alterations in Schizophrenia.基于网络的精神分裂症突触密度改变的分子制约因素
medRxiv. 2025 Mar 23:2025.03.22.25324465. doi: 10.1101/2025.03.22.25324465.
3
Synaptic Density in Early Stages of Psychosis and Clinical High Risk.

本文引用的文献

1
Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [F]SynVesT-1 PET in Parkinson's Disease.帕金森病中 [F]SynVesT-1 PET 参考区定量和减少扫描时间的初步评估。
Mol Imaging. 2023 Aug 11;2023:1855985. doi: 10.1155/2023/1855985. eCollection 2023.
2
Assessment of test-retest reproducibility of [F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A.评估新型正电子发射断层扫描显像剂[F]SynVesT-1 检测突触小泡糖蛋白 2A 重测信度的研究。
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1327-1338. doi: 10.1007/s00259-020-05149-3. Epub 2021 Jan 8.
3
精神病早期阶段及临床高危状态下的突触密度
JAMA Psychiatry. 2025 Feb 1;82(2):171-180. doi: 10.1001/jamapsychiatry.2024.3608.
4
Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [F]SynVesT-1 PET in Parkinson's Disease.帕金森病中 [F]SynVesT-1 PET 参考区定量和减少扫描时间的初步评估。
Mol Imaging. 2023 Aug 11;2023:1855985. doi: 10.1155/2023/1855985. eCollection 2023.
First-in-Human Assessment of C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer.
首例人体评估 C-LSN3172176,一种 M1 毒蕈碱型乙酰胆碱受体 PET 放射性配体。
J Nucl Med. 2021 Apr;62(4):553-560. doi: 10.2967/jnumed.120.246967. Epub 2020 Aug 28.
4
First-in-Human Evaluation of F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.人源化 F-SynVesT-1 的首次临床评估,一种用于突触囊泡糖蛋白 2A 的 PET 成像放射性配体。
J Nucl Med. 2021 Apr;62(4):561-567. doi: 10.2967/jnumed.120.249144. Epub 2020 Aug 28.
5
Simplified Quantification of C-UCB-J PET Evaluated in a Large Human Cohort.在大型人类队列中评估的 C-UCB-J PET 的简化定量。
J Nucl Med. 2021 Mar;62(3):418-421. doi: 10.2967/jnumed.120.243949. Epub 2020 Jul 9.
6
In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.使用 SV2A PET 对阿尔茨海默病进行广泛的突触丧失的体内测量。
Alzheimers Dement. 2020 Jul;16(7):974-982. doi: 10.1002/alz.12097. Epub 2020 May 13.
7
Assessment of a white matter reference region for C-UCB-J PET quantification.评估 C-UCB-J PET 定量的白质参考区域。
J Cereb Blood Flow Metab. 2020 Sep;40(9):1890-1901. doi: 10.1177/0271678X19879230. Epub 2019 Sep 30.
8
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: F-BCPP-EF, C-SA-4503, and C-UCB-J.用于量化健康人脑线粒体和突触功能的 3 种 PET 示踪剂的特征:F-BCPP-EF、C-SA-4503 和 C-UCB-J。
J Nucl Med. 2020 Jan;61(1):96-103. doi: 10.2967/jnumed.119.228080. Epub 2019 Jul 19.
9
Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates.新型正电子发射断层扫描(PET)放射性示踪剂用于非人类灵长类动物突触囊泡糖蛋白 2A(SV2A)成像的合成及体内评价。
ACS Chem Neurosci. 2019 Mar 20;10(3):1544-1554. doi: 10.1021/acschemneuro.8b00526. Epub 2018 Nov 16.
10
Quantifying SV2A density and drug occupancy in the human brain using [C]UCB-J PET imaging and subcortical white matter as reference tissue.利用 [C]UCB-J PET 成像和皮质下白质作为参考组织定量人脑中 SV2A 密度和药物占有率。
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):396-406. doi: 10.1007/s00259-018-4119-8. Epub 2018 Aug 18.